Luis Javier Leandro-García

5PUBLICATIONS
9CO-AUTHORS
Molecular targetsProteins and peptidesParticle physicsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 28, 2023
Mechanistic Insights of Thyroid Cancer Progression.

Luis Javier Leandro-García, Iñigo Landa

|May 28, 2022
Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248.

Alberto Díaz-Talavera, Cristina Montero-Conde, Luis Javier Leandro-García

|Feb 25, 2022
PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy.

Alberto Díaz-Talavera, Cristina Montero-Conde, Luis Javier Leandro-García

|Nov 13, 2020
Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma.

Sara Mellid, Javier Coloma, Bruna Calsina

|Jul 04, 2020
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome.

Juan María Roldan-Romero, María Santos, Javier Lanillos

Pageof 1

Frequent Collaborators

2 joint publications

Alberto Díaz-Talavera

2 joint publications

Cristina Montero-Conde

2 joint publications

Mercedes Robledo

1 joint publications

Bruna Calsina